RedHill Biopharma (RDHL) Net Margin Growth (1y) (2013 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) Net Margin Growth (1y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -2,064.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -303.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -1,110.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 383.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 406.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -10,766.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 543.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -129.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 4,369.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 324,467.00 |
| Mar 31, 2023 | -31,718.00 |
| Dec 31, 2022 | 11,486.00 |
| Sep 30, 2022 | -18,446.00 |
| Jun 30, 2022 | -6,003.00 |
| Mar 31, 2022 | 3,182.00 |
| Dec 31, 2021 | -72,837.00 |
| Sep 30, 2021 | 1,296.00 |
| Jun 30, 2021 | 5,320.00 |
| Mar 31, 2021 | -149,215.00 |
| Dec 31, 2020 | -67,418.00 |
| Sep 30, 2020 | -65,419.00 |
| Jun 30, 2020 | -84,341.00 |
| Mar 31, 2020 | 106,491.00 |
| Dec 31, 2019 | -16,812.00 |
| Sep 30, 2019 | 27,767.00 |
| Jun 30, 2019 | 54,599.00 |
| Mar 31, 2019 | 8,133.00 |
| Dec 31, 2018 | -291.00 |
| Sep 30, 2018 | -38,975.00 |